As economies worldwide are experiencing the impact of Covid-19, many face the challenge of a complete upheaval of lifestyle.

However, pharmaceutical companies are seeing positive growth on the stock market, as well as a fresh round of innovation in the infectious disease landscape, as the race for treatment approval for a Covid-19 therapy takes off.